On September 1, 2026 Immunocore Holdings plc (Nasdaq: IMCR) ("Immunocore" or the "Company"), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, reported management will participate at the following conferences in September.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cantor Global Healthcare Conference 2026
Fireside Chat: Thursday, September 10, 2026, at 2:45 p.m. EDT
Morgan Stanley 24th Annual Global Healthcare Conference
Fireside Chat: Monday, September 14, 2026, at 2:35 p.m. EDT
Baird 2026 Global Healthcare Conference
Fireside Chat: Tuesday, September 15, 2026, at 12:15 p.m. EDT
H.C. Wainwright 28th Annual Global Investment Conference
1×1 and small group meetings: Wednesday, September 16, 2026
The presentations will be webcast live and can be accessed by visiting ‘Events & Presentations’, under ‘Events’, via the ‘Investors’ section of Immunocore’s website at www.immunocore.com. Following the event, a replay of the presentation will be made available for a limited time.
(Press release, Immunocore, SEP 1, 2026, View Source [SID1234670487])